CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The DeShield project aims to enhance cancer treatment by developing a method to shield anti-cancer drugs until they reach tumor sites. This approach seeks to increase the effectiveness of treatments while reducing side effects on healthy tissues.
Cancer is one of the most prominent causes for morbidity and mortality in industrialized countries.
The key challenge in drug-based anti-cancer therapy is to efficiently kill the cancer cells while minimizing side-effects on healthy parts of the body.
The DeShield project will establish the proof of concept for a novel approach to upgrade existing anti-cancer drugs in a way that the anti-cancer effect will be increased while side-effects will simultaneously minimized.
DeShield technology will be…
ALBERT-LUDWIGS-UNIVERSITAET FREIBURG
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
